Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 23 | 21 | −2 |
| Shares | 2.40M | 2.21M | −191.5K (−8.0%) |
| Value | $3.52M | $4.17M | +$645.9K (+18.3%) |
New holders (2)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of New York Mellon Corp | 75,268 | $142.3K | 0.00% |
| JPMorgan Chase & Co | 10 | $19 | 0.00% |
Sold out (4)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| National Asset Management, Inc. | 90,298 | $132.7K |
| Susquehanna International Group, LLP | 11,715 | $17.2K |
| Millennium Management LLC | 10,436 | $15.3K |
| UBS Group AG | 8,616 | $12.7K |